The EASL Liver Cancer Summit 2025 has come to a close. We want to express our heartfelt gratitude to our delegates, faculty, organisers, and sponsors for your active engagement and enthusiasm throughout this extraordinary event!

The EASL Liver Cancer Summit 2025 counted 720 delegates from 51 countries, 45 faculty members, 12 EASL Sessions and 238 abstracts submitted.

Together, we’ve broadened our collective understanding of liver tumours and advanced the frontiers of research. CME credits will be awarded to all attendees.

Please note that all summit materials will be accessible on demand to registered delegates via the EASL Campus platform. This allows you the opportunity to review and delve into the wealth of information and insights presented during the summit at your convenience.

Thank you once again for your valuable contributions, and we eagerly anticipate your attendance in our future events!